TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 3.30nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 4.30nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 4.5nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 4.90nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 5.79nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 5.79nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 7.10nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 7.5nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 7.5nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 8.85nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 8.89nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 8.95nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 9.29nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 11.1nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 11.5nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 11.5nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 11.7nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 12.0nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 12.0nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 14.3nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 14.3nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 15.2nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 16.9nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 17.0nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 17.2nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 19.1nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 20.8nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 22.0nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 22.7nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 22.8nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 28.0nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 29.4nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair
TargetHLA class I histocompatibility antigen, A alpha chain(Human)
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Edward Jenner Institute For Vaccine Research
Curated by ChEMBL
Affinity DataIC50: 33.0nMAssay Description:MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)More data for this Ligand-Target Pair